Industries
|
Companies
|
Filings
|
News
|
CaseLaw
|
Annual Reports
|
UK
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Latest 424B2 SEC Filings
Prospectus [Rule 424(b)(2)]
EPIX MEDICAL INC, 424B2, 2001-01-17
BOSTON BIOMEDICA INC, 424B2, 2000-12-08
MATRITECH INC/DE/, 424B2, 2000-11-14
MATRITECH INC/DE/, 424B2, 2000-11-01
EPIX MEDICAL INC, 424B2, 2000-10-18
EPIX MEDICAL INC, 424B2, 2000-10-04
CYTOGEN CORP, 424B2, 2000-09-29
MATRITECH INC/DE/, 424B2, 2000-09-26
MATRITECH INC/DE/, 424B2, 2000-09-11
AVANT IMMUNOTHERAPEUTICS INC, 424B2, 2000-08-22
GENOME THERAPEUTICS CORP, 424B2, 2000-06-23
GEN TRAK INC, 424B2, 1999-11-18
DYNAGEN INC, 424B2, 1999-10-25
ABAXIS INC, 424B2, 1997-10-31
AVIGEN INC \DE, 424B2, 1996-11-22
CYTOGEN CORP, 424B2, 1996-11-07
CYTOGEN CORP, 424B2, 1996-09-30
CYTOGEN CORP, 424B2, 1996-09-05
ALLIANCE PHARMACEUTICAL CORP, 424B2, 1996-07-03
CYTOGEN CORP, 424B2, 1996-01-30
CYTOGEN CORP, 424B2, 1996-01-16
CYTOGEN CORP, 424B2, 1995-11-21
CYTOGEN CORP, 424B2, 1995-09-08
CYTOGEN CORP, 424B2, 1995-08-10
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission
